DiaMedica Therapeutics Inc. (DMAC)
DMACNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$9.66
0.0000 (0.00%) today
Pre-market, Nov 11, 4:00 PM ET
- Market cap
- $520.92m
- P/E
- –
- EPS, last 4 quarters
- $-0.7200
- Dividend yield
- –
- Day range
- –
- 52-week range
- $5.25 to $11.00
- Average volume
- –
- Previous close
- $9.66
Analysts
1 coveringBuy1 buy, 0 hold, 0 sell
Targets a year out average $12.00, +24.2% from here
Earnings
next estimate $-0.2000Next report
Sep 2025
-13.3%
Dec 2025
0.0%
Mar 2026
-11.8%
Jun 2026
0.0%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$9.03m | -$9.21m | -$10.48m | -$10.50m |
| Net income | -$8.62m | -$8.74m | -$10.04m | -$10.14m |
News
8 latest- Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a BetZacks · Aug 26, 2026
- DiaMedica (DMAC) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 17, 2026
- All You Need to Know About DiaMedica Therapeutics (DMAC) Rating Upgrade to BuyZacks · Aug 13, 2026
- DiaMedica Therapeutics Q2 Earnings Call HighlightsMarketBeat · Aug 11, 2026
- DiaMedica (DMAC) Q4 2025 Earnings TranscriptThe Motley Fool · Jun 1, 2026
- DiaMedica (DMAC) Q1 2026 Earnings TranscriptThe Motley Fool · May 8, 2026
- DiaMedica Therapeutics Q1 Earnings Call HighlightsMarketBeat · May 7, 2026
- DiaMedica Therapeutics Enters Oversold Territory (DMAC)BNK Invest · Apr 8, 2026
The company
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from serious ischemic diseases with a focus on preeclampsia, fetal growth restriction and acute ischemic stroke. DiaMedica's lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- diamedica.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.